| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |